The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1a/1b study of the safety, pharmacokinetics, and antitumor activity of ziftomenib in combination with imatinib in patients with advanced gastrointestinal stromal tumors (GIST) after imatinib failure.
 
Mark Agulnik
Consulting or Advisory Role - AADi; Boehringer Ingelheim; Daiichi Sankyo; SpringWorks Therapeutics
Speakers' Bureau - Deciphera
Research Funding - Exelixis (Inst)
 
Jason Sicklick
Stock and Other Ownership Interests - CureMatch; Oncureon, Inc.; Personalis
Consulting or Advisory Role - BlossomHill; CureMatch; Deciphera; GlaxoSmithKline; Kura Oncology; Kureha; SpringWorks Therapeutics
Speakers' Bureau - Deciphera; SpringWorks Therapeutics
Patents, Royalties, Other Intellectual Property - Methods for Diagnosing and Treating Drug Resistant Cancers (Inst)
Expert Testimony - Arias Sanguinetti; CUTT, KENDELL & OLSON
Travel, Accommodations, Expenses - Deciphera
 
Shreyaskumar Patel
Consulting or Advisory Role - Daiichi Sankyo; Deciphera; Kura Oncology; Thermosome
Research Funding - Ascendo (Inst); Kura Oncology (Inst)
 
Mrinal Gounder
Honoraria - Gerson Lehrman Group; Great Debates and Updates; Guidepoint Global; Med Learning Group; Medscape; MJH/PER; OncLive/MJH Life Sciences; Research to Practice
Consulting or Advisory Role - AADi; Ayala Pharmaceuticals; Epizyme; Ikena Oncology; Immunome; Kura Oncology; Orion Health; Rain Therapeutics; SpringWorks Therapeutics
Research Funding - AADi (Inst); Athenex (Inst); Ayala Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Erasca, Inc (Inst); Foghorn Therapeutics (Inst); GlaxoSmithKline (Inst); Ikena Oncology (Inst); Kymera (Inst); Orion Health; Rain Oncology (Inst); Regeneron (Inst); SERVIER (Inst); SpringWorks Therapeutics (Inst); Tango Therapeutics (Inst); Vivace Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - GODDESS PRO Desmoid Tumor (Inst); UpToDate
Travel, Accommodations, Expenses - Epizyme
Other Relationship - Desmoid Tumor Research Foundation
(OPTIONAL) Uncompensated Relationships - Foundation Medicine
 
Suzanne George
Stock and Other Ownership Interests - Abbott Laboratories (I); Pfizer (I)
Consulting or Advisory Role - Alexion Pharmaceuticals; Bluejay; deciphera; Kayothera; UpToDate
Research Funding - Acrivon Therapeutics (Inst); BioAtla; Blueprint Medicines (Inst); Deciphera (Inst); Eisai (Inst); IDRx (Inst); Merck (Inst); NewBay Pharma (Inst); Theseus Pharmaceuticals (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - UptoDate
Other Relationship - WCG
 
Rashmi Chugh
Consulting or Advisory Role - Cogent Biosciences; Deciphera; Recordati
Research Funding - Astex Pharmaceuticals (Inst); Cogent Biosciences (Inst); GlaxoSmithKline (Inst); Immunome (Inst); InhibRx (Inst); Kronos Bio (Inst); Kura Oncology (Inst); Novel Nobility (Inst); PharmaMar (Inst); Polaris (Inst); PTC Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Wolters Kluwer
Expert Testimony - Reminger Co, LPA
 
Michael Heinrich
Stock and Other Ownership Interests - von Pfeffel
Consulting or Advisory Role - Cogent Pharmaceuticals; Deciphera; Natera; New Bay; Novartis; von Pfeffel Pharmaceuticals
Travel, Accommodations, Expenses - Deciphera
 
David Liebner
Consulting or Advisory Role - Immunome
Patents, Royalties, Other Intellectual Property - Co-holder of 2 patents ("Methods for Predicting Prognosis") that has been licensed to a private company, MatchTX, LLC.
 
Vaia Florou
Consulting or Advisory Role - AADi; Deciphera; Ipsen; Merus; SpringWorks Therapeutics
 
John Rieth
Consulting or Advisory Role - Dicephera Pharmaceuticals, Inc.; EMD Serono
 
Pedro Viveiros
Honoraria - Deciphera; SpringWorks Therapeutics
Research Funding - Boehringer Ingelheim (Inst)
 
Daruka Mahadevan
Honoraria - Caris Life Sciences; Guardant Health
Speakers' Bureau - Caris Life Sciences; Guardant Health
Travel, Accommodations, Expenses - Caris Life Sciences; Guardant Health
 
Arun Singh
Leadership - Certis Oncology Solutions; Resolute Science
Stock and Other Ownership Interests - Certis Oncology Solutions
Honoraria - Galvanize Therapeutics
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Immunonome; Ipsen; Lilly
Speakers' Bureau - AADi; Daiichi Sankyo; Deciphera; Eisai; Lilly; MJH Life Sciences; Novartis; RAIN Therapeutics (Inst); Scripps Health; SpringWorks Therapeutics; TRACON Pharma (Inst)
Research Funding - Ayala Pharmaceuticals (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); deciphera (Inst); Intensity Therapeutics (Inst); Lilly (Inst); Nanocarrier (Inst); Polaris (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Deciphera; Eisai; Galvanize Therapeutics; Immunonome; Lilly; Novartis
Other Relationship - Certis Oncology Solutions
 
Vanessa Eulo
No Relationships to Disclose
 
Jonathan Trent
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Cogent Medicine; Daiichi Sankyo; Deciphera; Epizyme; SERVIER
 
Xiaoxian Dai
Employment - Kura Oncology
Stock and Other Ownership Interests - Kura Oncology
 
Ramya Antony
Employment - Kura Oncology
Stock and Other Ownership Interests - Kura Oncology
 
Daniel Corum
Employment - Kura Oncology
Stock and Other Ownership Interests - Kura Oncology
Patents, Royalties, Other Intellectual Property - Patents
 
Mollie Leoni
Employment - Kura Oncology
Leadership - Kura Oncology
Stock and Other Ownership Interests - Kura Oncology
Patents, Royalties, Other Intellectual Property - Patents with Kura oncology
Travel, Accommodations, Expenses - Kura Oncology; Kura Oncology
 
Margaret von Mehren
Honoraria - Boehringer Ingelheim; Deciphera; Von Pfeffel Corporation
Consulting or Advisory Role - deciphera; Von Pfeffel Pharma
Research Funding - ASCO (Inst); Cogent Biosciences (Inst); Deciphera (Inst); IDRx (Inst); Novartis (Inst); Sumitomo Pharma Oncology (Inst); Theseus (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; deciphera
Other Relationship - NCCN